Navigation Links
Shire Receives INTUNIV(TM) Paragraph IV Notice Letter From Anchen
Date:4/27/2010

45 days from the receipt of the Notice Letter to determine if it will file a patent infringement suit. If Shire brings suit pursuant to the Hatch Waxman regulations, a stay of approval of up to 30-months will be imposed by the FDA on Anchen's ANDA.

Notes to editors

SHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the extent they arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights. Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's website: http://www.shire.com.

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, the Company's results could be materially adversely affected. The risks and uncertainties include, but are not limited to, risks asso
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Excellent Results in a Transformational Year for Shire; Core Product Sales up 25%
2. Shire Presents Positive Efficacy and Safety Data for velaglucerase alfa in Treatment of Naive Patients With Type 1 Gaucher Disease
3. Shire Submits Biologics License Application (BLA) for REPLAGAL(R) With the U.S. Food and Drug Administration (FDA)
4. Shire Expands its Award-Winning ADHD Support Resource, ADHDSupport.com, by Launching an ADHD Twitter(TM) Page
5. Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic
6. Shire Announces Publication of Open-Label Study on Coadministration of INTUNIV(TM) (guanfacine) Extended-Release Tablets with Stimulants
7. Shire Re-Launches FOCUS, an Online, Personalized Patient Support Program for Adults with ADHD Taking Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII
8. Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD
9. Shire Continues to Deliver Excellent Growth From Core Products
10. Shire to Present Important Study Findings on its ADHD Treatments at a Major Psychiatric Meeting on October 29 and 30
11. Shire Presents Results of Five Lialda(R) (mesalamine) Analyses at ACG 2009 Annual Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 Dynatronics Corporation (NASDAQ: ... has been appointed to the Company,s Board of Directors ... the death in November 2014 of board member Joseph ... Linder to our Board of Directors represents an important ... , chairman and president of Dynatronics.  "Rich is a proven ...
(Date:3/27/2015)... 2015 /CNW Telbec/ - Russell Williams , President ... (Rx&D), welcomes the 2015-2016 Quebec Budget, noting the fiscal ... the biopharmaceutical industry. However, the association is concerned about ... commend the government,s intent to strive for a balanced ... promote Quebec,s economic development is ...
(Date:3/27/2015)...  Holographic Optical Technologies of Augusta, Georgia ... imaging, is entering the world of consumer electronics with ... 20 th , 2015, the campaign will introduce the ... 22-inch displays will allow consumers to view fully three ... addition to the two displays, the company will also ...
Breaking Medicine Technology:Dynatronics Announces Appointment of Richard J. Linder to Board of Directors 2Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 2Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 3Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 3
... SOMERSET, N.J., Jan. 30 Alfacell Corporation,(Nasdaq: ACEL ... occurred in the Phase IIIb clinical trial of its ... malignant,mesothelioma. Enrollment in the ONCONASE Phase IIIb clinical trial ... patients were enrolled in the,trial., In accordance with ...
... Breast ... Cancer Patients, EVERGREEN PARK, ... Centers in Evergreen Park, Illinois, near Chicago,( http://www.PursuingPainFreeCancer.org/breastcancer ), has announced ... for the,treatment of early stage breast cancer. The study involves the ...
Cached Medicine Technology:Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program 2Breast Cancer Treatment Is Reduced to One Week 2
(Date:3/27/2015)... York, New York (PRWEB) March 27, 2015 ... ( http://www.lipitorlawsuitcenter.com/ ) that allege the statin medication increases ... diabetes has granted Pfizer Inc.’s Motion to Dismiss four ... According to a Case Management Order issued in the ... 23rd, the Court determined that the dismissals were warranted ...
(Date:3/27/2015)... First Choice Emergency Room opened its new ... 12665 W Lake Houston Pkwy, Houston, Texas and is open ... forward to delivering the highest quality emergency medical care to ... First Choice Emergency Room Summerwood. , To celebrate ... Summer Creek High School at First Choice Emergency Room’s ribbon ...
(Date:3/27/2015)... 27, 2015 Bleeding is one ... percutaneous coronary intervention (PCI), resulting in increased mortality, ... “risk-treatment paradox,” in which the highest-risk PCI patients ... treated less often with bleeding avoidance strategies than ... Mid America Heart Institute asked the question whether ...
(Date:3/27/2015)... New York, NY (PRWEB) March 27, 2015 ... is seeing more plastic surgery patients travel to the ... Tania Medina. The plastic surgery clinic is turning the ... for international cosmetic surgery patients — with trustworthy services ... important factor when selecting a plastic surgeon. Patients are ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 Healthpointe is ... G. Katz, M.D., is now treating knee and hip ... Anaheim , Long Beach, and La Mirada. Dr. ... acute knee and hip joint disorders as well as ... is passionate in returning his patients back to their ...
Breaking Medicine News(10 mins):Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 2Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 3Health News:First Choice Emergency Room Opens New Facility in Houston, Texas 2Health News:Precision Medicine Improves Use of Bleeding Avoidance Strategies and Reduces Bleeding in Patients Undergoing Percutaneous Coronary Intervention 2Health News:Precision Medicine Improves Use of Bleeding Avoidance Strategies and Reduces Bleeding in Patients Undergoing Percutaneous Coronary Intervention 3Health News:Dominican Republic Plastic Surgery Provider Turning Medical Tourism Upside-Down 2Health News:Dominican Republic Plastic Surgery Provider Turning Medical Tourism Upside-Down 3Health News:Fellowship-Trained and Board-Certified Orthopedic Surgeon is Now Treating Knee and Hip Joint Disorders in Anaheim, California 2Health News:Fellowship-Trained and Board-Certified Orthopedic Surgeon is Now Treating Knee and Hip Joint Disorders in Anaheim, California 3
... zeroed in on a crucial gene, thought to be ... resistance// to long-term estrogen deprivation. The gene may be ... reappearance, and would enable a good idea to specialists ... research targeted breast cancer cells which had developed resistance ...
... The comradeship between doctors and medical representatives needs no ... the precincts of swank offices and boardrooms, where jet-setting ... targets. Propelled into action by sheer bottom-line figures, the ... doctor’s heart. ,The medical representatives first create ...
... to eat more by seeing the food ads on television, ... children// are more vulnerable to it. ,Researchers ... on Obesity in Budapest, said they exposed a group of ... series of food and toy adverts on television, followed by ...
... bird flu is also struggling to ensure that poor countries get ... ,Since the first case was reported two years ago, ... Indonesia - more than a third of the world's total. ... bird flu virus with the World Health Organization (WHO) since January. ...
... to bridge the gap in understanding schizophrenia, which affects ... how two of the dozen or more genes previously ... ,Prior genetic studies had linked schizophrenia to the ... in brain development, and erbB4, a receptor on brain ...
... School and the government of Kenya has jointly ... Food and Nutrition// Policy. The Friedman team, led ... Friedman School, is assisting the Kenyan government with ... plan. The scope of the plan ranges from ...
Cached Medicine News:Health News:Art of Establishing a Bond to Sell a Brand – Medical Reps Show the Wa 2Health News:Food Ads Prompts Children to Eat More 2Health News:Indonesia Struggles Against Bird Flu and the Drug Industry as Well 2Health News:Understanding of Schizophrenia Could Lead to New Treatment Options 2Health News:Understanding of Schizophrenia Could Lead to New Treatment Options 3Health News:Kenya to Implement National Food and Nutrition Policy 2Health News:Kenya to Implement National Food and Nutrition Policy 3
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
... Tendril SDX is one ... pacing leads. Implantable with a ... reduced body diameter is designed ... venous obstruction and allow introduction ...
Tendril DX active-fixation leads allows for lower thresholds initially and during the lead maturation phase....
Medicine Products: